Y53
5-(1~{H}-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol
Find entries where: Y53
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
|---|---|
| Name | 5-(1~{H}-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol |
| Identifiers | 5-(1~{H}-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol |
| Formula | C22 H27 N5 O2 |
| Molecular Weight | 393.482 |
| Type | NON-POLYMER |
| Isomeric SMILES | CC1(CC(CC(N1)(C)C)Oc2ccc(nn2)c3ccc(cc3O)c4c[nH]nc4)C |
| InChI | InChI=1S/C22H27N5O2/c1-21(2)10-16(11-22(3,4)27-21)29-20-8-7-18(25-26-20)17-6-5-14(9-19(17)28)15-12-23-24-13-15/h5-9,12-13,16,27-28H,10-11H2,1-4H3,(H,23,24) |
| InChIKey | STWTUEAWRAIWJG-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 56 |
| Chiral Atom Count | 0 |
| Bond Count | 59 |
| Aromatic Bond Count | 17 |
Drug Info: DrugBank
| DrugBank ID | DB14918 |
|---|---|
| Name | Branaplam |
| Groups | investigational |
| Description | Branaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)). |
| Synonyms | Branaplam |
| CAS number | 1562338-42-4 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL4290141 |
| PubChem | 135565042 |
| ChEMBL | CHEMBL4290141 |
